Swift of OTCs into quasi-drugs irks pharmacists

Published: 2008-05-23 06:59:00

Updated: 2008-05-23 06:59:00

The Korean Pharmaceutical Association said the government will reclassify some over-the-counter (OTC) products into quasi-drugs, rejecting speculation raised by news media.

The association reaffirmed in May 20 news briefing that the Ministry of Health, Welfare and Family Affairs will not push...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK